[EN] 3,4-DISUBSTITUTED MALEIMIDES FOR USE AS VASCULAR DAMAGING AGENTS<br/>[FR] MALEIMIDES 3,4-DISUBSTITUES UTILISES EN TANT QU'AGENTS DE DEGRADATION VASCULAIRE
申请人:ASTRAZENECA AB
公开号:WO2005102997A1
公开(公告)日:2005-11-03
This invention relates to novel compounds of Formula (I) for use as vascular damaging agents: Formula (I) wherein Rl, R7, R8, R9, ARI, AR2, AR3, p, q and r are as described in the specification. The invention also relates to methods for preparing compounds of Formula (I), to their use as medicaments (including methods for the treatment of angiogenesis or disease states associated with angiogenesis) and to pharmaceutical compositions containing compounds of Formula (I).
[EN] PROCESS FOR PREPARING PHOSPHORYLATED AMINO ACIDS<br/>[FR] PROCÉDÉ POUR PRÉPARER DES ACIDES AMINÉS PHOSPHORYLÉS
申请人:CEPHALON INC
公开号:WO2013012416A1
公开(公告)日:2013-01-24
The present invention provides a short, safe, inexpensive, commercially scalable process for preparing a phosphorylated amino acid of Formula I, which can be performed in one pot without isolating any synthetic intermediates.
[EN] PROCESS FOR PREPARING PHOSPHORYLATED AMINO ACIDS<br/>[FR] PROCÉDÉ DE PRÉPARATION D'ACIDES AMINÉS PHOSPHORYLÉS
申请人:CEPHALON INC
公开号:WO2013012846A1
公开(公告)日:2013-01-24
The present invention provides a short, safe, inexpensive, commercially scalable process for preparing a phosphorylated amino acid of Formula I, which can be performed in one pot without isolating any synthetic intermediates.
There are provided inter alia compounds of formula (I) wherein R
1
, R
2
, R
3
, R
4a
and R
4b
are as defined in the specification and their use in therapy, especially in the treatment of bacterial (e.g. pneumococcal) infections.